Zurcher Kantonalbank (Zurich Cantonalbank) Biotechnology

Zurcher Kantonalbank (Zurich Cantonalbank)

$32.8 Billion
Q3 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
RLAY Relay Therapeutics, Inc.	$537M	$152,000 0.0% of portfolio	21,514	Q1 2024 Added 12.26%
CGEM Cullinan Oncology, Inc.	$482M	$148,000 0.0% of portfolio	8,883	Q2 2024 Added 73.33%
SANA Sana Biotechnology, Inc.	$613M	$146,000 0.0% of portfolio	35,196	Q3 2024 Added 17.88%
ABUS Arbutus Biopharma Corp	$499M	$144,000 0.0% of portfolio	37,503	Q3 2024 Added 453.14%
SMMT Summit Therapeutics Inc.	$4.42B	$144,000 0.0% of portfolio	6,612	Q3 2024 Reduced 2.19%
MLTX Moon Lake Immunotherapeutics	$1.7B	$138,000 0.0% of portfolio	2,753	Q2 2024 Reduced 31.69%
TBPH Theravance Biopharma, Inc.	$626M	$136,000 0.0% of portfolio	16,978	Q3 2024 Added 29.1%
RGNX Regenxbio Inc.	$349M	$127,000 0.0% of portfolio	12,113	Q2 2024 Added 2.3%
ITOS I Teos Therapeutics, Inc.	$268M	$121,000 0.0% of portfolio	11,928	Q3 2024 Reduced 0.58%
IMNM Immunome Inc.	$134M	$117,000 0.0% of portfolio	8,011	Q2 2024 New
IBRX Immunity Bio, Inc.	$1.38B	$116,000 0.0% of portfolio	31,439	Q3 2024 Reduced 0.17%
STOK Stoke Therapeutics, Inc.	$453M	$112,000 0.0% of portfolio	9,129	Q2 2024 New
OLMA Olema Pharmaceuticals, Inc.	$247M	$110,000 0.0% of portfolio	9,282	Q4 2023 New
TNGX Tango Therapeutics, Inc.	$262M	$106,000 0.0% of portfolio	13,826	Q2 2024 Reduced 0.37%
NUVB Nuvation Bio Inc.	$502M	$99,000 0.0% of portfolio	43,050	Q2 2024 New
DAWN Day One Biopharmaceuticals, Inc.	$909M	$97,000 0.0% of portfolio	6,978	Q4 2023 Reduced 24.6%
SAGE Sage Therapeutics, Inc.	$431M	$96,000 0.0% of portfolio	13,320	Q1 2024 Added 8.68%
ALT Altimmune, Inc.	$326M	$90,000 0.0% of portfolio	14,688	Q2 2024 Added 190.68%
PLRX Pliant Therapeutics, Inc.	$520M	$90,000 0.0% of portfolio	8,030	Q1 2024 Added 43.39%
EYPT Eye Point Pharmaceuticals, Inc.	$274M	$86,000 0.0% of portfolio	10,874	Q3 2024 Reduced 0.13%
RVNC Revance Therapeutics, Inc.	$212M	$84,000 0.0% of portfolio	32,961	Q2 2024 Added 47.65%
ALEC Alector, Inc.	$137M	$82,000 0.0% of portfolio	17,730	Q2 2024 Reduced 0.17%
EDIT Editas Medicine, Inc.	$90M	$79,000 0.0% of portfolio	23,450	Q3 2024 Reduced 3.29%
SRRK Scholar Rock Holding Corp	$2.09B	$78,000 0.0% of portfolio	9,765	Q3 2024 Reduced 0.17%
CVAC Cure Vac N.V.	$710M	$74,000 0.0% of portfolio	25,477	Q2 2024 Added 0.0%
ALLO Allogene Therapeutics, Inc.	$259M	$63,000 0.0% of portfolio	22,551	Q4 2023 Added 55.37%
FDMT 4 D Molecular Therapeutics, Inc.	$176M	$61,000 0.0% of portfolio	5,712	Q2 2024 Reduced 0.31%
REPL Replimune Group, Inc.	$689M	$60,000 0.0% of portfolio	5,534	Q2 2024 Reduced 38.72%
ETNB 89bio, Inc.	$450M	$59,000 0.0% of portfolio	7,995	Q2 2024 Reduced 0.03%
ORIC Oric Pharmaceuticals, Inc.	$412M	$52,000 0.0% of portfolio	5,117	Q3 2024 Reduced 0.68%
YMAB Y M Abs Therapeutics, Inc.	$261M	$43,000 0.0% of portfolio	3,324	Q3 2024 New
LYEL Lyell Immunopharma, Inc.	$146M	$41,000 0.0% of portfolio	29,918	Q4 2023 Reduced 18.14%
VERV Verve Therapeutics, Inc.	$456M	$39,000 0.0% of portfolio	8,190	Q2 2024 Added 4.44%
CNTA Centessa Pharmaceuticals PLC	$1.6B	$35,000 0.0% of portfolio	2,199	Q3 2024 Reduced 1.57%
THRD Third Harmonic Bio, Inc.	$212M	$21,000 0.0% of portfolio	1,571	Q2 2024 Reduced 2.0%
ASND Ascendis Pharma A/S	$7.29B	$20,000 0.0% of portfolio	139	Q2 2024 Reduced 2.11%
AVXL Anavex Life Sciences Corp.	$723M	$16,000 0.0% of portfolio	2,830	Q3 2024 Reduced 1.8%
KALV Kal Vista Pharmaceuticals, Inc.	$217M	$16,000 0.0% of portfolio	1,411	Q3 2024 Reduced 1.74%
ACIU Ac Immune Sa	$233M	$13,000 0.0% of portfolio	3,663	Q3 2024 Reduced 4.88%
CHRS Coherus Bio Sciences, Inc.	$91.7M	$11,000 0.0% of portfolio	10,613	Q3 2024 Reduced 21.58%
QURE Uni Qure N.V.	$736M	$11,000 0.0% of portfolio	2,376	Q3 2024 Reduced 27.12%
CDXS Codexis, Inc.	$274M	$10,000 0.0% of portfolio	3,493	Q3 2024 Reduced 20.36%
AUTL Autolus Therapeutics PLC	$203M	$9,000 0.0% of portfolio	2,564	Q2 2024 Reduced 2.62%
MGTX Meira G Tx Holdings PLC	$283M	$9,000 0.0% of portfolio	2,351	Q3 2024 Reduced 1.76%
FULC Fulcrum Therapeutics, Inc.	$219M	$8,000 0.0% of portfolio	2,475	Q2 2024 Reduced 0.28%
IMCR Immunocore Holdings PLC	$1.44B	$7,000 0.0% of portfolio	244	Q3 2024 Reduced 1.61%
ALLK Allakos Inc.	$20.3M	$5,000 0.0% of portfolio	8,911	Q3 2024 Reduced 21.75%
MGNX Macrogenics Inc	$188M	$5,000 0.0% of portfolio	1,707	Q3 2024 Reduced 89.38%
SGMO Sangamo Therapeutics, Inc	$193M	$5,000 0.0% of portfolio	6,116	Q3 2024 Reduced 27.12%
BTAI Bio Xcel Therapeutics, Inc.	$9.25M	$3,000 0.0% of portfolio	6,028	Q3 2024 Reduced 8.36%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.